Long-term benefit from anti-hormonal treatment is influenced by menopausal status

Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low-risk tumors have a long-term benefit for at least 20 years, while the benefit was more short-term for younger women with similar tumor characteristics who had not yet gone through the menopause.

from Top Health News -- ScienceDaily https://ift.tt/1ABTgIu